FDA publishes updated PQ/CMC Document for Comments

Recommendation
Thursday, 13 February 2025 10.30 - 15.45 h
Focus on CADIFA and obtaining a Brazilian GMP certificate
In March, the U.S. FDA published the draft of the "Pharmaceutical Quality/Chemistry Manufacturing and Controls (PQ/CMC) Data Exchange" document for comments.
This document is part of a project, which has been in place since 2017 and includes the standardisation and structuring of submitted data from the PQ/CMC area in Module 3 of the electronic Common Technical Document (eCTD) . The following points are the central cornerstones of this project:
- The development of standards for the structured presentation of PQ/CMC data.
- The development of a standard exchange system to submit the structured PQ/CMC data to the U.S. FDA.
Already in 2017, the U.S. FDA had published the first draft of the document and convened a public meeting regarding the project in 2018. The summaries of this are also available on the U.S. FDA website.
Here you can find the draft version of the "Pharmaceutical Quality/Chemistry Manufacturing and Controls (PQ/CMC) Data Exchange" for the electronic submission of PQ/CMC data. The draft is available for comment until mid-May!
Related GMP News
10.02.2025ANVISA: Updated Version of the CADIFA Manual available
05.02.2025US FDA: Carcinogenic Potency Categorization Approach for Nitrosamine Impurities
05.02.2025IPEC: Version 3 of GDP Guide available
29.01.2025EDQM: Supplement 11.8 to the European Pharmacopoeia available
22.01.2025Elemental Impurities: Harmonized chapter finalized
22.01.2025ECHA: Update on PFAS Restrictions